 |
인쇄하기
취소
|
Green Cross to conduct clinical trial for novel immunotherapy
Patients with lymphoma can rest assured that science and technology are finding their way to improving options in cancer care using the body's immune system through the field of immunology.
Green Cross Corporation said on March 22 that it has received an approval from the Korea Food and Drug Administration to conduct its clinical study for adoptive immunotherapy, which focuses on the expansi...
Green Cross Corporation said on March 22 that it has received an approval from the Korea Food and Drug Administration to conduct its clinical study for adoptive immunotherapy, which focuses on the expansi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.